Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

What You Need to Know Ahead of Edwards Lifesciences' Earnings Release

Based in Irvine, California, Edwards Lifesciences Corporation (EW) is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. With a market cap of $55.34 billion, Edwards Lifesciences is renowned for its cutting-edge technologies, including heart valve therapies and hemodynamic monitoring systems, designed to enhance patient outcomes. The company operates worldwide, emphasizing innovation, quality, and patient care. EW is set to announce its fiscal Q2 earnings results after the market closes on Wednesday, Jul. 24.

Ahead of the event, analysts expect EW to report a profit of $0.70 per share, up 6.1% from $0.66 per share in the year-ago quarter. The company has consistently beaten or matched Wall Street’s EPS estimates in its last four quarterly reports. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.